Sibert et al, Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers, Nature Communications (2024). DOI: 10.1038/s41467-024-50162-x ...

Brass et al. 1 used fluorescence microscopy to score the abundance of the influenza envelope glycoprotein hemagglutinin as a marker of infection with influenza A/PR/8/34 (PR8) virus in siRNA ...

Human metapneumovirus (hMPV), a negative, single-stranded RNA virus, accounts for approximately ... have generated an hMPV fusion glycoprotein (“F protein”) stabilized in a prefusion conformation.

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

LASSARAB is a deactivated rabies virus (RABV)-based vaccine encoding the glycoprotein precursor (GPC) of Lassa fever virus. The trial will enroll up to 55 healthy adults between the ages of 18 and ...